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Abstract 
 
When nanocarriers are administered into blood circulation, a complex biomolecular layer known as the ‘protein corona’ 
associates with their surface. Although the drivers of corona formation are not known, it is widely accepted that this layer 
mediates biological interactions of the nanocarrier with its surroundings. Label-free optical methods can be used to study 
protein corona formation without interfering with its dynamics. We demonstrate the proof-of-concept for a multi-
parametric surface plasmon resonance (MP-SPR) technique in monitoring the formation of a protein corona on surface-
immobilized liposomes subjected to flowing 100% human serum. We observed the formation of formulation dependent 
‘hard’ and ‘soft’ coronas with distinct refractive indices, layer thicknesses and surface mass densities. MP-SPR was also 
employed to determine the affinity (KD) of a complement system molecule (C3b) with cationic liposomes with and 
without polyethylene glycol. Tendency to create a thick corona correlated with a higher affinity of opsonin C3b for the 
surface. The label-free platform provides a fast and robust preclinical tool for tuning nanocarrier surface architecture and 
composition to control protein corona formation.  
 
1. Introduction 
 
Nanomedicine has advanced several research fields (e.g. cancer and gene therapy, medical imaging) by enabling the 
targeted delivery of therapeutic and diagnostic molecules while protecting the sensitive cargo [1,2]. Hydrophilic 
molecules, such as polyethylene glycol (PEG), are used to shield nanocarriers from unspecific protein binding that may 
change biodistribution, decrease cellular uptake, and lead to premature nanocarrier clearance by the mononuclear 
phagocyte system (MPS) [3]. In fact, PEG can increase the average circulation time of liposomal drugs from minutes to 
up to days [3]. However, it is widely accepted that the steric hindrance provided by PEG and other hydrophilic coatings 
does not abrogate unspecific protein binding, and these coatings can act as immune activators [4–7]. Since severe 
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hypersensitivity reactions to nanocarriers have been reported in clinical use, improved preclinical methods to assess the 
safety of nanocarriers are needed [2,4,5,8–10]. In particular, label-free methods to predict biological interactions of 
nanocarriers are warranted, as labels may lead to biased results [2,11]. The safety of nanocarriers can be improved by 
decreasing the immunogenicity of nanocarriers, or by increasing their cellular targeting, both of which are affected by the 
proteins adsorbed on the nanocarrier surface.  
After nanocarrier introduction into blood circulation, their surface is rapidly covered with a complex and dynamic layer 
of biomolecules such as proteins, lipids and other plasma components [3,12–14]. This layer is often referred to as the 
“protein corona” and it is further divided into a stable “hard corona” and a diffuse secondary layer of proteins, the “soft 
corona” [3,12–14]. Following the pioneering work of Cedervall et al.[14] to characterize the kinetics of protein corona 
formation on nanoparticle surfaces, protein-nanocarrier interactions have received increasing attention [15,16]. At 
present, the influence of the protein corona on the fate of the nanocarriers in the body has been clearly demonstrated 
[3,11,13,17]. Proteomic characterization of the protein corona has helped to identify nanocarrier-specific protein 
fingerprints – not a simple task considering the highly dynamic nature of the protein corona [15,17–20]. More recently, 
the focus has shifted towards exploiting protein corona formation for extracellular and intracellular targeting, 
understanding its evolution, and its role in mediating physiological responses to nanocarriers [8,15,17,20]. However, there 
is still a need to increase our understanding of the protein corona phenomenon and its dynamics due to its biological 
significance.  
The prevailing hypothesis on the dynamics of corona formation assumes the formation of a highly dynamic but slowly-
developing hard corona with a limited number of proteins [11,14,18]. This paradigm was challenged by Tenzer et al. [17], 
who reported the formation of a highly complex and particle-specific protein corona on all nanoparticles tested in 30-
seconds. The rapid formation and composition of the protein coronas could not be explained merely by the 
physicochemical properties of the nanoparticles, and at longer incubation times, the protein composition changed only 
quantitatively but not qualitatively [17]. According to the authors, the rapid formation of a protein fingerprint is sensible 
considering the highly dynamic nature of physiological systems, which have evolved to “react instantly” to preserve 
homeostasis. The effect of dynamic incubation on protein corona formation was recently demonstrated with PEG-
modified liposomes when static incubation was compared to a flow conditions mimicking blood flow dynamics [12]. 
Over 200 corona proteins were identified, with 108 proteins common to both incubation conditions, whereas 10 and 99 
proteins were observed only after incubation in static or dynamic conditions, respectively [12]. For increased in vivo 
relevance, the protein corona formation should therefore be tested in flow conditions. 
The studies by Palchetti et al.[12] and Tenzer et al.[17] indicate the presence of complement system proteins in the corona. 
This is not surprising considering the nature of these proteins as the probes of the immune system, and the non-allergic 
hypersensitivity reactions that have been reported following the administration of PEGylated liposomes (e.g. Doxil©) that 
has been linked to complement system activation [5,9]. For instance, covalent deposition of C3b on the surface of 
nanocarriers lead to an increased MPS clearance rate and a tendency to activate an innate immune response [3,21,22]. 
C3b is an activated opsonin formed from the central complement protein C3, at which all three activation pathways 
converge for amplification [21]. Complement proteins can carry out their functions by binding both to the native 
nanocarrier surface or through attachment to surface-bound proteins such as albumin [23]. Therefore, for reduced 
immunogenicity, nanocarrier surfaces should not favor the binding of C3b or other complement components [5,9,21].  
Most analytical techniques are not suitable to study the soft corona on nanocarriers [12,16,17,20]. Biophysical analytical 
approaches to monitor the soft corona could provide important information, and there is a growing interest in Raman 
spectroscopy, quartz crystal microbalance (QCM) and surface plasmon resonance (SPR) to study the evolution of corona 
formation in real-time [16,20]. The SPR phenomenon has been widely used for biosensing applications, including the 
interaction kinetics of individual proteins and complement system components on biomaterial surfaces [24]. Previous 
SPR studies on the interactions of nanocarriers with blood proteins have employed diluted plasma [13,23,25]. The surface 
of biosensors can be functionalized with specific chemistries of interest, proteins, or a hydrogel and lipid matrix that can 
be used to capture nanocarriers on the sensor surface – an approach we utilize in this work among others [14,25–27].  
SPR permits the sensitive label-free monitoring of molecular interactions [28,29]. It is based on propagating waves of 
surface plasmons produced on a metal surface upon excitation with light. The conditions for exciting the surface plasmons 
are dependent on the refractive index of the medium in contact with the metal surface, and the molecular mass changes 
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on the metal surface. In essence, the binding of molecules such as proteins to the metal surface can be detected as a change 
in the SPR peak angular position, θSPR. Figure 1 illustrates a set of idealized full SPR angular spectra; the solid red and 
blue traces representing measured spectra, and the black and orange dotted lines showing calculated counterparts for the 
red and blue spectra, respectively. The main components of spectra are marked as ① the angular position of total internal 
reflection (TIR) event, and ② the angular position of SPR peak minimum, referred to as θSPR in this manuscript. As the 
analytes are deposited onto the sensor surface, a shift towards larger angular values takes place in the θSPR (Figure 1, ②
). However, the angular position of TIR may also undergo a change towards larger values if the refractive properties of 
running buffer and injected analyte differ significantly (Figure 1, ①). This bulk effect, in turn, can be compensated for 
in the θSPR and thus the remaining part of the angular change mainly represents the binding event at the surface. In general, 
the full SPR angular spectra contain all the physical information to solve for the layer thicknesses and refractive indices; 
the shape and quantities associated with the SPR curve are utilized. A more profound mathematical description of solving 
for the layer thickness and refractive index is given in Materials and Methods section. Lastly, it is worthwhile pointing 
out, that the full SPR angular spectra are used to solve for deposited layer thicknesses and refractive indices whereas the 
sensorgrams are utilized for determining the interaction kinetics parameters. Importantly, in the sensorgrams the θSPR 
(displayed in Figure 1 as red and blue dots) is followed in real time which allows for calculating the kinetic parameters 
if the injected analyte concentrations are known.  
 
Figure 1. An idealized example of two measured full SPR angular spectra (red and blue solid curves) and the fitted spectra (black and 
orange dotted curves, respectively). The shape and quantities associated with the SPR curve are used to fit the measured data and 
consequently, solve for surface-deposited layer thicknesses (d) and refractive indices (n). The calculation is carried out in a step-wise 
numerical iteration routine whereby the parameters (d and n) for each layer are calculated utilizing the information provided by two 
independent excitation wavelengths (670 nm and 785 nm). For clarity, instead of displaying four measured curves, spectra recorded 
from one wavelength are depicted in the figure. The shift in angular position of total internal reflection (TIR) is used to compensate for 
bulk effect caused by the differences between running buffer and injected sample; e.g. serum injection into the flow system consisting 
of running buffer induces a significant change in the TIR angle (①). In order to estimate the signal for the binding event to the surface, 
the TIR shift contribution can be compensated by a subtraction from the overall signal. In general, binding events are detected as a 
shift in θSPR (②).  
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Multi-parametric surface plasmon resonance (MP-SPR) refers to an adaptation of the SPR technology that can be used to 
optically characterize biomolecular layers in more detail and with thicknesses of up to several micrometers [28] (Figure 
1). Traditionally, the incident angle of minimum reflectance has been monitored over a narrow angular area near the θSPR. 
With the MP-SPR technique, the full SPR angular spectrum is recorded by scanning over a wide angular range (~40-78 
degrees) and multiple parameters can be acquired simultaneously; for example the angular position of the TIR angle, the 
angular position of θSPR, the half-width of the main SPR peak and the change in the main SPR peak intensity at θSPR can 
be monitored in real-time. The combination of two or more wavelengths and a scanning angle feature makes it possible 
to record the entire SPR angular spectrum as a function of time. Unlike with other SPR instruments that employ only one 
wavelength, the MP-SPR adaptation allows for determination of layer thicknesses, refractive indices and surface mass 
densities in addition to traditional kinetic association and dissociation events [28,30,31]. These features provide new 
opportunities for a more detailed surface characterization of protein coronas, which we have explored in this work. In this 
paper, we describe the proof-of-concept for a MP-SPR method to monitor the formation of protein coronas on nanocarriers 
in real-time at the interface of flowing undiluted serum. We also demonstrate the use of MP-SPR to determine the affinity 
of a complement system probe molecule C3b interaction with the sensor-immobilized liposome surface. 
2. Materials and Methods 
 
Serum preparation. Blood drawn from seven healthy and fasted donors using Vacutainer glass tubes without clot 
activator (BD, Franklin Lakes, NJ, USA) was left to clot for 30 min at 22C, followed by centrifugation at 2500 × g for 
5 min and 3500 × g for 5 min. The serum fractions were collected manually and pooled together with serum from other 
donors in aseptic conditions, and stored in aliquots at -80C. Before SPR measurements, aliquots were thawed rapidly in 
a 37ºC water bath until 90% thawed. Heat homogeneity was checked with a FLIR TG165 imaging IR thermometer (FLIR 
Systems, Inc., OR, USA) to avoid bubble formation inside the SPR flow channel due to temperature changes. 
Liposome samples. The film re-hydration method followed by extrusion through a polycarbonate membrane was used 
to prepare liposome samples [32]. Control liposomes were replicas of the Doxil© (Johnson and Johnson, NJ, USA; 
marketed in Europe under the name Caelyx© by Janssen-Cilag International NV, Beerse, Belgium) formulation with and 
without PEG (referred to as DOX+PEG and DOX, respectively) but without doxorubicin[32]. The molar ratio of fully 
hydrogenated soy phosphatidylcholine (HSPC), cholesterol and N-(carbonyl-methoxypolyethylene glycol 2000)-1,2-
distearoyl-sn-glycero-3-phosphoethanolamine sodium salt (DSPE-PEG2000) or 1,2-distearoyl-sn-glycero-3-
phosphoethanolamine (DSPE) was 55:40:5, respectively[32]. After preparation the DOX and DOX+PEG liposome stock 
suspensions were stored at 4C until use. For SPR measurements, the DOX and DOX+PEG liposome samples were 
adjusted to a 3 mM total lipid concentration. 
Positively charged liposomes with oligo-guanidyl lipid derivative (OGD) with a 0.2 mg/ml total lipid concentration in 
HEPES 10 mM and NaCl 150 mM (pH 7.4) buffer solution were freeze dried after preparation and stored at -20C until 
use[33]. For SPR measurements, the OGD liposomes samples were quickly thawed and vortexed. The OGD liposomes 
adsorbed on the sensor surface were then coated in situ according to a charge-to-charge association process with a 
polyanionic-PEG block-copolymer (PEG) with a concentration of 0.1085 mg/ml in HEPES 10 mM and NaCl 150 mM 
(pH 7.4) buffer solution (OGD+PEG).  
Endotoxin detection. The presence of endotoxins was tested using Limulus Amoebocyte Lysate (LAL) assays: Pierce 
LAL chromogenic endotoxin quantitation kit (Thermo Fisher Scientific, Waltham, MA, USA) and Pyrogent Plus Gel 
Clot LAL at 0.06 EU/ml sensitivity (Lonza, Basel, Switzerland). Assays were performed according to manufacturers’ 
instructions using endotoxin-free consumables. Test samples were incubated using a Thermomixer C heating block 
(Eppendorf AG, Hamburg, Germany). Absorbance (405 nm) was measured using a Spectrostar Nano plate reader (BMG 
Labtech, Ortenberg, Germany) and calculated using the accompanying MARS software. Inhibition and enhancement 
controls and transmissivity measurements of the liposome solution at assay wavelength were performed to rule out 
liposome interference with the LAL assays.  
Physicochemical characterization of liposome samples. Hydrodynamic diameter measurements were performed at 25 
C with a Zetasizer APS DLS automated plate sampler (Malvern Instruments, Malvern, United Kingdom). Results are 
reported as size distributions (average hydrodynamic diameter  S.D.) derived from relative signal intensities and in the 
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form of a polydispersity index (PDI). Surface charge of the liposomes was determined by measuring the ζ-potential in 
DTS 1070 folded capillary cells (Malvern Instruments) by using a Zetasizer Nano ZS instrument (Malvern Instruments).  
MP-SPR measurements. Measurements were performed with a SPR NaviTM 200 (BioNavis Ltd., Ylöjärvi, Finland) 
instrument. The setup was equipped with two incident laser wavelengths, 670 nm and 785 nm, two independent flow 
channels, inlet tubing and outlet (waste) tubing. Both of the flow channels were measured in parallel with 670 nm and 
785 nm incident light. The measurement temperature was kept constant at 20 °C, and the flow rates used for liposome 
immobilization and for serum interactions were 50 µL/min and 100 µL/min, respectively. Liposomes were captured and 
immobilized on SPR sensors consisting of a thin 6 kD carboxymethyl dextran hydrogel layer functionalized with dodecyl 
lipid anchors [26,34]. The SPR sensors were used repeatedly after rejuvenation with an injection series of Hellmanex II 
2% (Hellma Analytics, Müllheim, Germany) or CHAPS 20 mM (Sigma-Aldrich), ethanol 80% (Altia Oyj, Rajamäki, 
Finland) and deionized water from a Milli-Q water purification system (Merck KGaA, Darmstadt, Germany). In between 
measurements, the sensors were stored immersed in CHAPS at 4°C. During the SPR measurements, the functionalized 
gold sensor slides were first subjected to the running buffer for respective liposome for approximately 5-10 minutes until 
a stable baseline was achieved. In the second phase, the liposomes were injected into both flow channels for 10 minutes, 
and lastly, sensor surfaces containing the immobilized liposome species were subjected to 100% serum. The PEGylation 
step for the OGD liposomes was performed in situ with a polyanionic-PEG block-copolymer after liposome 
immobilization to create a surface with OGD+PEG, whereas DOX+PEG liposomes contained PEG prior to 
immobilization.  
 
MP-SPR data analysis. The shape and quantities associated with the SPR curve are utilized for the layer thickness and 
refractive index calculations. The SPR spectrum can be described with Fresnel’s equations as the reflectivity of a 
multilayered system for p-polarized light [28,30]. In essence, the layers are assumed linear, homogenous, and isotropic. 
The calculation is based on a 2 X 2 scattering matrix that is derived from Fresnel’s complex-amplitude reflection and 
transmission coefficients. The matrix represents the summarized optical properties of the system; the properties are 
expressed as a product of the interface and layer matrices of the entire structure. Furthermore, the intermediate zones 
between different layers are introduced into Fresnel’s equations as new layers. Thus, the thickness of the intermediate 
layer describes the average roughness of the surface whereas its complex refractive index corresponds to the light losses 
via scattering and plasmon decoupling into radiative modes (essentially the imaginary part of the complex refractive 
index). The benefit of this approach is that only Fresnel’s equations can be used without the need to apply e.g. scattering 
theories. In practice, the modeling and solving for the matrix formalism is performed by mathematical fitting tools or 
dedicated software. To solve for the layer thicknesses and refractive indices of the thin biomolecular layers, a two-
wavelength method combined with angular scanning over a wide range of incident light angles is particularly efficient 
[35–37]. The measured full angular SPR spectrum and matrix formalism are utilized to model the layers. Even though 
the overall mathematics behind the calculations is relatively complicated, the solving process can be simplified to a level 
that the modeling still produces accurate results for most of the situations that deal with common materials and biological 
molecules. Additionally, the sources for error are feasible to track due to the known limitations of these evaluations. It is 
worth emphasizing that the multi-wavelength approach for surface characterization has been successfully implemented 
in previous studies [26,31,38,39].  
 
The general solution for a multilayered, optically active system that is connected with measurable and controllable 
quantities, can be derived using the aforementioned transfer matrix formalism of 2 X 2 matrices. In the complex refractive 
index ?̂? = 𝑛 + 𝑖𝑘 the real part n corresponds to the refraction of light, and the complex coefficient k to the extinction or 
absorption of light by the material. Furthermore, the relationship ?̂? = √𝜀 ̂ connects the refractive index and dielectric 
constant. Finally, in practical experiments, the surface plasmon wave vector (ksp) is considered to contain all the 
information and constants that affect the measured SPR spectra, and lead to differences in SPR spectra measured at 
multiple wavelengths. Therefore, the continuum solution for surface plasmon wave vector (ksp) in one set of conditions 
can be deducted to describe the mathematical relationship between (ksp), the material layer thickness d, and the refractive 
index n: 
k𝑠𝑝 ∝ 𝑛 ∗ 𝑑 
 
However, the definition above describes only one continuum solution for the (ksp). The unique solution for the apparently 
interconnected thickness d and refractive index n of the sample layer build in the given experimental conditions can be 
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found from the intersection of two continuum solutions. Therefore a measurement in two different media or multiple 
wavelengths is needed [28,31]. In the mathematical treatment of the two-wavelength method, the refractive index n has 
also a wavelength dependency, dn/dλ. The unique solution for layer thickness d and refractive index n can be found by 
solving for the equations: 
 
𝑘𝑠𝑝1 = 𝑛𝜆1 ∗ 𝑑 
𝑘𝑠𝑝2 = 𝑛𝜆2 ∗ 𝑑 
 
where 𝑘𝑠𝑝1 denotes the surface plasmon vector for wavelength 1, 𝑛𝜆1 the refractive index for wavelength 1, 𝑘𝑠𝑝2  the 
surface plasmon vector for wavelength 2, and 𝑛𝜆2 the refractive index for wavelength 2, and: 
 
𝑛𝜆2 =  𝑛𝜆1 +
𝑑𝑛
𝑑𝜆
∗ (𝜆2 − 𝜆1) 
and: 
𝑘𝑠𝑝1 = 𝑛𝜆1 ∗ 𝑑 
𝑘𝑠𝑝2 =  (𝑛𝜆1 +
𝑑𝑛
𝑑𝜆
∗ (𝜆2 −  𝜆1)) ∗ 𝑑 
 
The statements above hold true for sample layers that do not absorb light at the wavelengths used in the SPR spectrum 
measurement. In practice, it means that the imaginary component k for the refractive index = 0, which is the case for the 
majority of organic sample layers. However, if the layer absorbs light, 𝑘 ≠ 0, and there is a unique solution for the sample 
layer in the 𝑘𝑠𝑝 = (𝑛 + 𝑖𝑘) ∗ 𝑑 space. One can utilize laser wavelengths 670 nm and 785 nm that are aligned to irradiate 
simultaneously the same spot in each sample channel. The thicknesses of modeled layers can be linked as common for 
both wavelengths in the modeling step, i.e. the layer thickness is expected to be the same for both wavelengths since the 
SPR angular spectra are measured from the same spot. The complex refractive index can be input as an independent 
variable for background (e.g. pure metal layer) modeling, or as a linearly dependent variable between the two used 
wavelengths for reasons described above. 
 
The SPR Navi LayerSolver v. 1.2.1 (BioNavis Ltd., Ylöjärvi, Finland) software was used for the layer thickness (d) and 
refractive index (n) modeling and calculations. In essence, the modeling and calculation of layer thickness and refractive 
index were carried out using the two-wavelength method. The LayerSolver allows for multiple SPR spectra processing, 
and a step-wise approach for calculations where the biophysical properties of the molecular layers are determined by 
numerical iteration one layer at a time. The software was used to simultaneously solve the thickness and refractive index 
based on full SPR angular spectra measured with two different wavelength lasers (670 nm and 785 nm) at the same time 
point [28,30]. The numerical iteration is performed by the embedded algorithms in LayerSolver software. The equations 
described in section “MP-SPR data analysis” constitute the physical cornerstone for the calculation routines in 
LayerSolver. As input variables, the following layer thickness and refractive index values were used: for OGD, d = 45-
70 nm and n = 1.357-1.355; for DOX, d = 80-120 nm and n = 1.357-1.352; for OGD and DOX soft corona, d = 20-70 nm 
and n = 1.37-1.38; for OGD and DOX hard corona d = 5-10 nm and n = 1.38-1.39. In the optical modeling performed in 
this work, the thickness values were defined as global variables for the two wavelengths used and the refractive indices 
were defined as independent variables for the iteration cycles.  
 
Interaction kinetics were modeled with TraceDrawer v. 1.6 (Ridgeview Instruments AB, Vänge, Sweden) software. The 
calculation of interaction parameters is based on well-established kinetic models [40]. Herein, a one binding site model 
was used for determining the affinity of the human native complement component C3b (diluted in Dulbecco’s phosphate 
buffered saline, obtained from Merck KGaA, Darmstadt, Germany) interacting with immobilized OGD or OGD+PEG 
liposomes. According to the supplier, the C3b protein used should display at least 60% of its physiological activity. A 
concentration series 0.00833, 0.0833, and 0.833 mol (determined with a MW of 180 kDa from 0.0015, 0.015, and 0.15 
mg/ml) fitting with negligible dissociation phases was performed for the measured C3b sensorgrams in order to calculate 
the kinetic parameters for C3b. In general, molecular mass that binds onto the SPR sensor surface has a well-defined 
correlation with the observed SPR angular spectrum and the SPR resonance angle shift in particular. Hence, the surface 
mass densities of C3b can be calculated by using the de Feijter equation that is derived from the definition of refractive 
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index increment of adsorbing biomolecules, with some limitations [41,42]. For the used SPR NaviTM 200 instrument and 
670 nm laser wavelength, the actual surface mass density conversion coefficient can be defined using a value of  𝑑𝑛 𝑑𝑐⁄  
= 0.182 cm3/g. In this study, to convert the observed SPR signal responses to surface mass densities (Γ), we used the 
conversion factor Δ 1 mdeg = Δ (Γ) ~0.6 ng/cm2 for the lower limit of deposited surface mass density. To estimate the 
error in the calculation, we also defined the higher limit using the conversion factor Δ 1 mdeg = Δ (Γ) ~1.0 ng/cm2.  
 
 
3. Results and Discussion 
 
Liposome immobilization and serum interaction with the immobilized liposomes. Figure 1 illustrates the measurement 
scheme for serum interaction studies with the liposomes. Undiluted serum was used instead of anticoagulated plasma 
since it contains a functioning complement system. Roman numerals are used consistently to refer to the modeled physical 
events. Figures 2 and 4 (A and B), and Figures 3 and 5 (A and B) display the MP-SPR sensorgrams and full SPR 
angular spectra, respectively, with: (I) the liposome layer after immobilization onto the sensor surface, (II) serum 
interaction with liposomes and ensuing soft corona formation, and (III) the hard corona after restoration of buffer flow. 
In this work, the term soft corona is used to refer to the combination of a denser corona layer accompanied by a more 
diffuse layer of weakly interacting proteins. The averages of the modeled and calculated layer thicknesses (d) and 
refractive index (n) values of three independently repeated measurements are found in Table 1 for OGD and OGD+PEG 
liposomes and in Table 2 for DOX and DOX+PEG liposomes. In order to emphasize the highly dynamic behavior of the 
modeled systems, to take into account the possible sensitivity of differential equations to initial conditions provided as 
inputs in LayerSolver, and to estimate the uncertainties in experimental procedures and calculations, we chose to define 
a range for the calculated (d) and (n) values. Thus, instead of representing one set of (d) and (n) values, our intention was 
to determine the dlow and nlow as well as dhigh and nhigh, between which the calculated values could potentially vary. The 
dlow, nlow, dhigh, and nhigh values were calculated by using a consistent set of initial values throughout the layer modeling. 
Table S1 presents the results of physicochemical characterization (size, PDI and ζ-potential) and endotoxin 
determination. The results for each individual experiment are found in Table S2 for OGD and OGD+PEG liposomes and 
Table S3 for DOX and DOX+PEG liposomes. In order to show that the observed events are not dependent on the flow 
channel used, the immobilized liposome species were interchanged between the flow channels from experiment to 
experiment.  
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Fig. 2 Schematic representation of the experimental setup using a MP-SPR Navi™ 200 instrument (instrument image courtesy of 
BioNavis Ltd., Ylöjärvi, Finland). A: Liposomes were captured from inflow and immobilized onto functionalized sensors. 
Measurements were run in parallel with the same serum source to compare the effect of hydrophilic coating molecules on protein 
corona formation. B: Simplified representation of the sensor surface to demonstrate the distinct layers of interest in the modelling step. 
Roman numerals indicate (I) the OGD liposome layer after immobilization onto the sensor and in situ functionalization with the 
polyanionic-PEG block-copolymer (blue), (II) serum interaction with liposomes and following soft corona formation, and (III) the hard 
corona after restoration of buffer flow.       
 
OGD and OGD+PEG liposome interaction with 100% serum. Figure 3A shows the real-time sensorgrams from one 
measurement demonstrating OGD liposome immobilization onto the SPR sensor in both channels, followed by the 
PEGylation step in channel 2 (CH2) at t~30 min to form OGD+PEG. In channel 1 (CH1) with plain OGD liposomes, the 
signal remains at a constant level during running buffer injection. Figure 3B and Table 1 present the serum interaction 
results.  
 
 
 
Fig. 3 MP-SPR sensorgrams for immobilization of OGD liposomes and their interaction with serum. A: Liposome immobilization to 
both channels with PEG modification in situ at t~30 min for CH2. Thickness (d) and refractive index (n) of liposome layers have been 
modeled and calculated at time point I. B: Serum interaction (from 40-60 min) with the immobilized OGD (CH1) or OGD+PEG (CH2) 
liposomes at a flow speed of 100 µL/min. Thickness (d) and refractive index (n) were modeled and calculated at II for soft corona, and 
at III for hard corona after restoration of buffer flow.  
 
Figure 4 (A and B) present the full SPR spectra from real-time experiments for OGD and OGD+PEG liposomes at time 
points when the upper and lower boundaries for layer thicknesses and refractive indices were determined. First, the 
functionalized gold sensor surface with a 6 kDa carboxymethyl dextran hydrogel matrix with dodecyl lipid anchors was 
measured and modeled (black line), followed by the (I) immobilized liposome layer, (II) soft corona and (III) hard corona. 
For clarity, the measured metal layer and OGD or OGD+PEG liposome layers are displayed without the fitted curves, 
whereas the soft and hard corona layers are depicted with both measured and fitted curves. Based on the step-wise 
numerical iteration procedure in LayerSolver, where the previous layer acts as a background to solve for the thickness 
and refractive index of the consequent layer, the modeling yields fairly good alignment between the calculated and 
measured SPR spectra throughout the procedure. Typically, the SPR angular peak minimum tends to shift towards larger 
angles as molecules (mass) adsorbing onto the surface and consequently change the refractive index in close vicinity to 
the surface. Thus, the surface plasmon coupling condition undergoes a change that can be observed as a shift in the peak 
minimum angular position [27,43,44]. The biomolecular layer build-up is clearly seen in Figure 4 (insets in A and B) 
where the SPR peak minimum shifts from the value observed for the metal (black traces) to the right when liposomes are 
associating with the surface (red traces) and both the total internal reflection (TIR) angle and the SPR peak minimum 
shifts further to the right when a soft corona forms (blue solid trace and the corresponding fitted purple dashed line). 
Interestingly, when the hard corona layer is revealed after restoration of buffer flow, the peak minimum value shifts back 
to the left (green solid traces and the navy blue dashed fitted lines) – which is an expected phenomenon when serum with 
a much higher refractive index is replaced by a buffer solution with lower refractive index (affects mainly TIR angular 
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position) and when components of the looser soft corona layer dissociate, leaving a denser layer on the surface of 
immobilized liposomes. 
 
 
Fig. 4 Layer modeling for OGD and OGD+PEG liposomes using the measured full SPR angular spectra. A: SPR peak minimum shifts 
for the measured and modeled phases from the metal sensor surface (black line) to plain OGD (I) liposome immobilization, (II) soft 
corona, and (III) hard corona. B: Corresponding events for OGD+PEG. 
 
Table 1. OGD and OGD+PEG liposomes and serum interaction results. The calculated values are low and high limits for layer thickness 
(d) with corresponding refractive index (n) values as averages ( standard deviation) of three independent measurements for: (I) 
immobilized OGD liposomes with and without PEG modification; (II) soft protein corona formation following serum interaction; and 
(III) the residual hard corona after buffer flow restoration when a stable baseline is observed.  
 (I) Liposome  (II) Soft corona (III) Hard corona 
O
G
D
 
 Low High Low High  Low High 
d 40.4 ± 9.3 55.5 ± 16.0 34.2 ± 2.1 106.0 ± 17.4 9.6 ± 1.0 16.4 ± 0.9 
n 
1.35302 
± 0.0021 
1.34996 
± 0.00151 
1.39701 
± 0.0080 
1.37742 
± 0.0016 
1.44627 
± 0.0072 
1.41121 
± 0.0035 
O
G
D
+
P
E
G
 
 Low High Low High Low High 
d 44.4 ± 4.2 60.9±8.1 22.2 ± 14.5 63.2 ± 57.2 4.6 ± 2.7 8.6 ± 6.4 
n 
1.35679 
± 0.00292 
1.35263 
± 0.00215 
1.37931 
± 0.0178 
1.38013 
± 0.0071 
1.39524 
± 0.0393 
1.37531 
± 0.0227 
Refractive indices extracted during fitting procedure: serum 1.34960, buffer 1.33535. 
 
As shown in Table 1, the immobilized OGD liposomes form on average a slightly thinner layer on the sensor surface 
(40.4-55.5 nm) compared to the PEGylated OGD layer (44.4-60.9 nm), with basically the same refractive index for both 
systems. The slightly larger thickness for the ODG+PEG layer can be attributed to the additional PEG layer deposited on 
the adsorbed OGD liposome layer, whereas the additional PEG layer will not significantly affect the refractive index due 
to the high water content in the PEG layer. Although MP-SPR signal response levels exceeding ~500 mdeg suggest that 
saturation of the sensor was achieved by both OGD and OGD+PEG, it is noteworthy that the SPR curve produced by 
MP-SPR is an average of the entire sensor surface; factors such as the non-homogeneous placement of liposomes, gaps 
in the layers, or the formation of multilayers can also influence the layer thicknesses and refractive indices observed [45]. 
Morphological changes in the shape of the liposome due to the interactions with the functionalized sensor surface and the 
shear stress from buffer flow are also expected, and they account for the differences to hydrodynamic diameters measured 
in bulk (Table S1).  
 
Following serum injection, a thicker soft corona layer (34.2-106.0 nm) forms on the plain OGD liposome layer compared 
to the OGD+PEG liposome layer (22.2-63.2 nm). The plain OGD liposome layer presents surface charges that favor the 
association of passing serum components. Moving beyond the presumption that steric PEG protection decreases protein 
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adsorption to liposome surfaces, we hypothesize that this observation can be explained by higher opsonisation and 
possible surface-induced activation of the complement system by the OGD liposome bearing oligo-guanidyl moieties and 
traces of endotoxin (Table S1) [12,21,24]. Complement activation leads to the recruitment of other complement 
components and formation of enzyme convertases that amplify the activation process by catalyzing opsonin production 
and their surface deposition in high quantities, thereby producing more molecular mass on the surface [21,24]. The 
tendency to activate the complement system is influenced by the amount and orientation of PEG molecules on the surface 
of liposomes [5,46,47]. However, the standard deviation of soft corona layer thickness in the case of OGD+PEG is 
relatively large (± 57.2 at upper boundary) and a more definitive conclusion warrants further studies. Despite the 
difference in soft corona layer thicknesses, refractive indices in the same range for OGD and OGD+PEG suggest a similar 
consistency, presumably related to the more diffuse and rapidly exchanging nature of the soft corona layer at the vicinity 
of the surface. Finally, when a buffer rinse is performed after serum injection, a significantly thicker and denser hard 
corona layer remains on the surface of the plain OGD liposomes compared to OGD+PEG, which may report of 
complement activation and deposition of covalently bound complement end products onto the surface. To our knowledge, 
this is the first time when MP-SPR is used to optically characterize properties of protein corona layers. These results 
provide clear support for the existence of a distinct, more diffuse soft corona layer on top of the hard corona [13,17,20].  
 
DOX and DOX+PEG liposome interaction with 100% serum. Figure 5 and 6 show the real-time sensorgrams and the 
full angular SPR spectra, respectively, for DOX and DOX+PEG liposomes. The layer thicknesses and refractive indices 
are shown in Table 2. In Figure 4A, DOX liposomes without PEG were immobilized to CH1 and DOX+PEG to CH2. 
Since DOX+PEG liposomes were already PEGylated ex situ, a separate functionalization step on the sensor was not 
needed. The clearly larger signal response for the DOX liposome layer compared to the DOX+PEG liposome layer can 
be explained by the different penetration properties of the liposomes into the carboxymethyl dextran hydrogel matrix and 
interactions with the dodecyl lipid anchors depending on liposome properties. Lundquist and her colleagues have 
demonstrated that the hydrophilic PEG coating on liposomes decreases interactions with lipid anchors, preventing deep 
penetration into the carboxymethyl hydrogel matrix on the Biacore L1 chip [48]. The lower layer thickness for DOX+PEG 
liposomes could therefore be a result of smaller penetration PEGylated liposomes into the hydrogel, and stronger 
interaction of the plain DOX liposomes with the dodecyl moieties. It is important to note, however, that layer thicknesses 
and refractive indices cannot be interpreted solely by visual inspection of the sensorgrams. For example, the sensorgram 
in Figure 5 (B, II) shows a higher signal for DOX+PEG liposomes during soft corona formation, but in Table 2 (II) the 
average calculated soft corona layer thickness is slightly smaller for DOX+PEG liposomes. To explain these occasional 
abnormalities in signal behavior in brief, the modeled layer thickness (d) and refractive index (n) are dependent on the 
relative SPR peak minimum shift compared to the previous (lower) layer and its SPR peak minimum position, as well as 
the intensity fluctuations and SPR minimum peak width observed in the SPR angular spectra. Our modeling approach is 
a layer-by-layer evaluation procedure where the next layer is built by using the previous layer as a starting point for 
subsequent steps, in particular the protein corona determinations at II and III. Since the initial signal levels of DOX 
liposome immobilization compared to DOX+PEG are significantly higher (Figure 5, A), this difference can be expected 
to have a distorting effect on the subsequent protein corona modeling steps. Therefore, in addition to performing accurate 
modeling and calculations based on the full angular SPR curves and using data from several reproducible experiments, 
careful inspection of the signal levels at these different phases is needed in order to correctly interpret the phenomena 
taking place at the surface or in its near vicinity. Layer thicknesses and refractive indices for subsequent serum interactions 
were calculated as described previously. As previously perceived in the layer modeling process for OGD and OGD+PEG, 
hereby a similar observation can be made on the relatively good alignment between the measured and calculated SPR 
spectra.  
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Fig. 5 MP-SPR sensorgram for DOX and DOX+PEG liposome immobilization and interaction with serum. A: Liposome 
immobilization onto the sensor surface with DOX in CH1 and DOX+PEG in CH2. The liposome layer thickness has been modeled 
and calculated at time point I. B: Serum interaction (from 35-55 min) with DOX (CH1) or DOX+PEG (CH2) liposomes at a flow speed 
of 100 µL/min. Thickness (d) and refractive index (n) were modeled and calculated for soft corona (II) and hard corona (III) after 
restoration of buffer flow. 
 
 
Fig. 6 Layer modeling for DOX and DOX+PEG liposomes using the measured full SPR angular spectra. A: SPR peak minimum shifts 
for the measured and modeled phases from the metal sensor surface (black line) to plain DOX (I) liposome immobilization, (II) soft 
corona, and (III) hard corona. B: Corresponding events for DOX+PEG. 
 
Table 2. DOX and DOX+PEG liposomes and serum interaction results. The calculated values are low and high limits for layer thickness 
(d) with corresponding refractive index (n) values as averages ( standard deviation) of three independent measurements for: (I) the 
immobilized DOX and DOX+PEG liposome layer; (II) soft protein corona formation following serum interaction; and (III) the residual 
hard corona after buffer flow restoration when a stable baseline is observed.  
 (I) Liposome  (II) Soft corona (III) Hard corona 
D
O
X
 
 Low High Low High  Low High 
d 99.1 ± 5.0 153.2 ± 8.2 37.5 ± 1.7 86.8 ± 19.6 3.4 ± 1.2 6.6 ± 1.9 
n 
1.36237 
± 0.0010 
1.35680 
± 0.0009 
1.41742 
± 0.0046 
1.42930 
± 0.0175 
1.39440 
± 0.0034 
1.38614 
± 0.0063 
D
O
X
+
P
E
G
  Low High Low High Low High 
d 37.3 ± 4.7 49.1 ± 2.9 25.8 ± 4.8 60.0 ± 18.0 7.6 ± 0.9 13.0 ± 0.8 
n 
1.34971 
± 0.0017 
1.34722 
± 0.0002 
1.39711 
± 0.0069 
1.37730 
± 0.0026 
1.42353 
± 0.0075 
1.39187 
± 0.0085 
Refractive indices extracted during fitting procedure: serum 1.34960, buffer 1.33535. 
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Table 2 represents the modeled and calculated values of DOX liposomes forming on average a 99.1-153.2 nm layer on 
the sensor surface with an average refractive index of 1.35680-1.36237. The immobilized DOX+PEG liposomes form a 
significantly thinner layer with an average of 37.3-49.1 and with a lower refractive index range of 1.34722-1.34971. We 
speculate that the exceedingly high signal produced by plain DOX liposomes is a consequence of its lipophilic interactions 
with the lipid anchors, promoted by the smaller size and absence of oligo-guanidyl moieties comparing to plain OGD 
liposomes, which are likely to lead to the formation of liposome multilayers instead of monolayers on the sensor surface 
[45,48]. After serum injection, a soft corona of 37.5-86.8 nm forms on DOX liposomes with a refractive index of 1.41742-
1.42930, whereas the layer thickness on DOX+PEG is slightly thinner 25.8-60.0 ± 18.0 nm. As with the liposome layer, 
the refractive index range of the DOX+PEG soft corona layer is lower 1.37730-1.39711. After restoration of buffer flow, 
a significantly thinner hard corona remains on DOX compared to DOX+PEG (3.4-6.6 vs. 7.6-13.0 nm). Interestingly, the 
refractive index of DOX hard corona is lower than the soft corona for the same liposome, or the hard corona observed on 
DOX+PEG (1.38614-1.39440 vs. 1.39187-1.42353, respectively). We hypothesize that these could be explained by a 
higher amount of light refracting species remaining at the vicinity of the surface, but may also be caused by events such 
as restructuring and phase transformations taking place in the biomolecular layers [49]. Based on the observations on the 
possible distorting effect of the significantly higher signal response in the DOX liposome immobilization step, contrasting 
DOX liposome results reliably with the three other liposome types would require further optimization of sensor saturation 
levels. Therefore, for proof-of-concept, we limit our discussion to compare protein corona formation on OGD and 
OGD+PEG to DOX+PEG as a “benchmark” liposome formulation. 
 
Comparison of OGD and OGD+PEG with DOX+PEG serum interaction events. When the serum interaction events 
described in Tables 1 and 2 are compared, some important observations can be made. Firstly, refractive indices of soft 
corona layers on OGD and OGD+PEG liposomes are clearly smaller than the refractive indices of soft corona layers on 
DOX+PEG liposomes. This disparity is not dependent on the liposomes having PEG or not. This may be in relation to 
the differences in the properties of these liposome species, for example surface lipophilicity or hydrophilicity, surface 
charge and rheological properties, which translate into different compositions for the protein corona [17,26]. Secondly, 
OGD liposomes favor a soft corona layer formation that is slightly thicker and denser than in the case of OGD+PEG or 
DOX+PEG liposomes (34.2-106.0 vs. 22.2-63.2 and 25.8-60.0 nm, respectively). Absence of PEG increases the 
lipophilicity of the surface, and increased protein binding is expected [49]. Dynamic conditions may also contribute to 
this effect, as protein coronas formed on PEG-modified liposomes under dynamic conditions tends to be thicker than 
those resulting from static incubations, i.e. around 20-25 nm thicker [12]. For OGD and in a lesser extent for OGD+PEG, 
the presence of OGD oligo-guanidyl moieties and traces of endotoxin on the surface might also attract specific serum 
components, as we discussed earlier [15]. Thirdly and most interestingly, the plain OGD liposomes induce the formation 
of a thicker (9.6-16.4 nm) and denser (1.41121-1.44627) hard corona layer as a result of interaction with serum 
components compared to the other liposome samples. This is in line with the results of Walczyk et al.[13], who presented 
a range of 11-12 nm for “protein shell thickness” prior to extensive washing and around 10.5 nm after washing using 
differential centrifugal sedimentation of polystyrene model nanoparticles incubated for up to 6 hours with diluted plasma.  
 
C3b interaction with immobilized OGD and OGD+PEG liposomes. Using MP-SPR, we determined the affinity and 
surface density mass of the opsonin C3b on the OGD and OGD+PEG liposome surfaces. This was done in order to gain 
insight whether the observed differences in the serum interaction studies could be explained at least in part by 
immunogenic properties of the nanocarriers – the increased tendency to recruit opsonins from the serum and, possibly, 
activate the complement system. C3b is a 180 kDa fragment that results from the cleavage of anaphylatoxin C3a from 
complement component C3 [21,24]. C3b is able to covalently bind to amino or hydroxyl groups on artificial surfaces 
through its exposed thioester [21,24]. After immobilization of OGD or OGD+PEG liposomes to sensor surfaces in parallel 
channels, a series of C3b concentrations was injected into both channels: 0.00833, 0.0833, and 0.833 mol. As shown in 
Figure 7, a clearly larger stepwise SPR response signal is achieved in terms of C3b interacting with OGD surface without 
PEG (A) in comparison to OGD liposome surface with PEG (B). The calculated results for deposited C3b surface mass 
densities were Γ(total) ~410-680 ng/cm2 for OGD liposomes without PEG, and Γ(total) ~120-200 ng/cm2 for OGD 
liposomes with PEG. These results are consistent with the findings of the serum interaction measurements. The calculated 
equilibrium dissociation constants for C3b match up reasonably well between the different liposome interaction schemes: 
for C3b interacting with OGD and OGD+PEG, KD,OGD = 3.8  10-8 M and KD,OGD+PEG = 7.2  10-8 M were obtained, 
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respectively. To the best of our knowledge, this is the first time the C3b affinities have been determined on biomaterial 
surfaces and on intact surface-immobilized liposomes. 
 
 
Fig. 7 C3b binding affinity and surface mass density onto OGD and OGD+PEG liposomes. 
 
Based on these results, we demonstrate a connection between the tendency of the surface to adsorb serum components 
and a preference of C3b for the surface. Hence, the observed differences in interaction experiments of OGD liposomes 
with undiluted serum, as discussed above, may be in relation to complement system activation. In particular, the observed 
significant difference in the hard corona composition formed onto the OGD liposome layer without PEG may report that 
the OGD liposomes without PEG are capable of inducing more drastic opsonisation-related responses than the OGD 
liposomes with PEG. Unfortunately, since the OGD liposomes (but not the PEG added to functionalize these liposomes 
in situ to form OGD+PEG) used were shown to contain traces of endotoxins, it is not possible to reliably link increased 
opsonisation to PEG conformation or liposome properties at this stage. However, these observations merit further studies 
using other complement trigger molecules, as well as assays to confirm complement activation taking place at the surface, 
such as using antibodies specific to C3b degradation products such as C3c [25].  
 
In summary, we have demonstrated a convenient way to bind clinically relevant samples of nanocarriers to sensor surfaces 
and to study their interactions with full serum. Our focus was on intact liposomes that we modified with hydrophilic 
coating molecules before and after immobilization to sensor, which has not been reported previously. This method can 
be applied with relative ease to assess the effect of different surface modifications on unspecific protein binding with 
different types of nanocarriers. The main limitation in the present work was the use of serum instead of plasma; for 
instance, fibrinogen that is not present in serum is known to bind to PEG-coated liposomes [12]. This is explained in part 
by our interest in the complement activating properties of surface-immobilized liposomes, which cannot be studied in 
EDTA-anticoagulated plasma. We demonstrated that undiluted serum can be successfully used in the interaction studies, 
but we suggest that any blood product without cells – such as plasma or serum that has been depleted of some component 
or associated to a certain disease state – is equally suited for this experimental setup. In regard to the safety of nanocarriers, 
the possibility to link the production of secondary inflammatory mediators to surface events would provide 
complementary evidence of the immunogenic properties of nanocarriers. Even though it is difficult to replicate the in vivo 
conditions in blood circulation in vitro, the dynamic flow and temperature-controlled conditions improve the in vivo 
relevance of the presented method. Using MP-SPR and layer-by-layer modeling, we were able to separately identify 
distinct soft and hard coronas. The possibility to identify and elute these biomolecular layers from the surface of 
nanocarriers might provide interesting opportunities: for example, coupling MP-SPR technology to other analysis 
instruments such as LC-MS could permit dissecting subclasses of the protein corona, and producing snapshots of the 
protein corona at different times [16,17,20].  
 
4. Conclusions 
 
In this study, we have developed a flexible, highly modifiable and sensitive one-instrument MP-SPR technology platform 
that can be used for interaction studies using undiluted serum with nanocarriers in controlled dynamic settings. We 
 14 
explored its essential capabilities with four different liposomes and conclude that MP-SPR is suitable for optical 
characterization of the formation and evolution of protein coronas on nanocarrier surfaces. Our reproducible 
measurements clearly demonstrated the formation of a distinct soft corona. In addition, we were able to determine binding 
affinity (KD) for an essential opsonin, C3b, directly on a biomaterial surface. Therefore, the described label-free platform 
provides a powerful preclinical tool for tuning nanocarrier surface architecture and composition to control protein corona 
formation.  
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Supplementary Materials 
 
Table S1. Physicochemical characterization and endotoxin determination results for DOX, DOX+PEG, OGD and OGD+PEG 
liposomes. Results are presented as average ( standard deviation) for hydrodynamic diameter and ζ-potential. Results for endotoxins 
are reported in EU/ml and described as positive (+) and negative (-) based on two complementary assays. 
 Hydrodynamic 
diameter 
Polydispersity index  ζ-potential Endotoxin 
DOX 98.12  14.80 nm 0.324 -1.42  0.16 mV <0.1 EU/ml (-) 
DOX 
+PEG 
105.07  2.64 nm 0.017 -1.90  0.17 mV <0.1 EU/ml (-) 
OGD 227.03  19.28 nm 0.254 +20.10  0.40 mV >1.0 EU/ml (+) 
OGD 
+PEG 
248.43  30.40 nm 0.328 -1.84  0.41 mV >1.0 EU/ml (+)a 
a) OGD+PEG liposome tested after the charge-to-charge association process tested positive for endotoxin, but the polyanionic-PEG 
block-copolymer solution alone contained <0.1 EU/ml of endotoxin. 
 
 
Table S2. The compiled modeling results of separate experiments for OGD and OGD+PEG liposomes and serum interactions. The 
calculated values are low and high limits for layer thickness (d) with corresponding refractive index (n) values from all three 
independent measurements and their average ( standard deviation). Refractive indices extracted during fitting procedure: serum 
1.34960, buffer 1.33535. 
 
 (I) Liposome  (II) Soft corona (III) Hard corona 
O
G
D
 
 Low High Low High Low High 
1 39.97 51.08 32.7 94.28 9.73 16.0 
2 31.31 42.15 33.37 97.72 10.5 17.45 
3 49.88 73.27 36.61 126.05 8.59 15.79 
d 
40.3867 ± 
9.29201 
55.5 ± 16.0239 
34.2267 ± 
2.09104 
106.017 ± 
17.4344 
9.60667 ± 
0.96095 
16.4133 ± 0.9039 
1 39.97 1.35166 1.40034 1.37681 1.44632 1.41075 
2 31.31 1.34876 1.40279 1.37927 1.45346 1.41491 
3 49.88 1.34947 1.38789 1.37619 1.43904 1.40797 
n 
1.35302 
± 0.0021 
1.34996 
± 0.00151 
1.39701 
± 0.00799 
1.37742 
± 0.00163 
1.44627 
± 0.0072 
1.41121 
± 0.0035 
O
G
D
+
P
E
G
 
 Low High Low High Low High 
1 48.0 61.94 22.63 54.75 3.2 4.99 
2 45.44 68.51 36.53 124.19 7.73 15.99 
3 39.72 52.35 7.5 10.64 2.99 4.8 
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d 
44.3867 
± 4.23931 
60.9333 
±8.1269 
22.22 ± 14.5193 
63.1933 ± 
57.2439 
4.64 ± 2.67808 8.6 ± 6.4 
1 1.35643 1.35295 1.38403 1.37284 1.3802 1.36849 
2 1.35987 1.35461 1.39426 1.38047 1.43979 1.40062 
3 1.35406 1.35034 1.35963 1.38709 1.36573 1.35681 
n 
1.35679 
± 0.00292 
1.35263 
± 0.00215 
1.37931 
± 0.01779 
1.38013 
± 0.00713 
1.39524 
± 0.03925 
1.37531 
± 0.02269 
 
 
Table S3. The compiled modeling results of separate experiments for DOX and DOX+PEG liposomes and serum interactions. The 
calculated values are low and high limits for layer thickness (d) with corresponding refractive index (n) values from all three 
independent measurements and their average ( standard deviation). Refractive indices extracted during fitting procedure: serum 
1.34960, buffer 1.33535. 
 
 (I) Liposome  (II) Soft corona (III) Hard corona 
D
O
X
 
 Low High Low High  Low High 
1 104.01 161.5 39.48 88.5 3.85 7.45 
2 93.98 145.02 36.32 105.39 1.98 4.39 
3 99.16 153.05 36.63 66.41 4.26 7.81 
d 99.05 ± 5.015905 
153.19 ± 
8.240892 
37.47667 ± 
1.741848 
86.76667 ± 
19.54772 
3.363333 ± 
1.215415 
6.55 ± 1.879255 
1 1.36309 1.35754 1.42127 1.4351 1.39668 1.39222 
2 1.36128 1.35579 1.42137 1.40966 1.39603 1.37973 
3 1.36275 1.35706 1.41862 1.44315 1.39048 1.38648 
n 
1.362373 
± 0.000962 
1.356797 
± 0.0009 
1.41742 
± 0.00457 
1.429303 
± 0.017481 
1.39440 
± 0.00341 
1.38614 
± 0.00625 
D
O
X
+
P
E
G
 
 Low High Low High Low High 
1 40.8 50.64 20.27 51.26 6.65 12.17 
2 31.98 45.78 27.62 48.07 8.25 13.57 
3 39.2 50.87 29.36 80.68 7.96 13.36 
d 
37.3267 ± 
4.69895 
49.0967 ± 
2.87462 
25.75 ± 4.8249 
60.0033 ± 
17.9774 
7.62 ± 0.85247 
13.0333 ± 
0.75501 
1 1.34788 1.34742 1.40478 1.38021 1.41521 1.38219 
2 1.35118 1.34706 1.39126 1.37628 1.42977 1.39814 
3 1.35008 1.34719 1.39528 1.3754 1.42562 1.39527 
n 
1.34971 
± 0.00168 
1.34722 
± 0.00018 
1.39711 
± 0.00694 
1.37730 
± 0.00256 
1.42353 
± 0.0075 
1.39187 
± 0.0085 
 
